FDA Watch: Agency Launches Database of Complete Response Letters Sent to Drug Manufacturers About Initial Rejections
The early focus is on drug applications, but it could spread to the laboratory test approval process as well
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
The early focus is on drug applications, but it could spread to the laboratory test approval process as well
John Osiecki of bioMérieux also discusses AI for outbreaks and regulation trends
The $14.6 billion bust by federal prosecutors shows gaps that every laboratory should monitor
Learn how CLIA could be used as a blueprint to regulate emerging technologies in an effective and dynamic way
Washington State’s Department of Health details how its medical testing site program meets federal standards
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments